iPSC-derived, disease-specific cell models serve as an opportunity to study pathophysiological mechanisms and can lead to the development of new treatments. We provide locally derived human pluripotent stem cell lines and generate induced pluripotent stem cell (iPSC) lines from somatic cells provided by the client. BSCC operates on a fee-for-service basis in providing custom iPSC derivation using the latest technologies. BSCC is a part of the life science infrastructure of HiLife GoEditStem platform and the Stem Cells and Biomaterials consortium, national Biocenter Finland technology platform.
BSCC is equipped with basic cell culture equipment such as laminars, incubators, centrifuges and microscopes. Further information.
BSCC Director Timo Otonkoski, timo.otonkoski@helsinki.fi or BSCC Coordinator Ras Trokovic, ras.trokovic@helsinki.fi
Biomedicum Helsinki, Biomedicum Stem Cell Center, 5th floor, Haartmaninkatu 8, Meilahti Campus
The research infrastructure is supported by the University of Helsinki (HiLIFE) and Biocenter Finland. The prices are listed below.
Product | Volume | University of Helsinki price | BF network price | Comercial price |
---|---|---|---|---|
Use of IncuCyte | 1 plate/h | 2 € | 3 € | 4 € |
hPSC distribution | 1 ampoule | 150 € | 203 € | 485 € |
hiPSC generation* from fibroblast/blood | 2 characterized clones, frozen at passage ten and 2-4 uncharacterized clones frozen at passage 3 |
2200 € | 3113 € | 6213 € |
Early hiPSC generation** from fibroblast/blood | 4-6 uncharacterized clones frozen at passage 3 | 1000 € | 1436 € | 2678 € |
Miscellaneous | 1 h | 25 € | 33 € | 86 € |
Genome editing | On-demand | - | - | |
Endoderm lineage diff. | On-demand | - | - |
* and ** We guarantee the derivation of two hiPSC lines from the cells provided by the client. In the case reprogramming is not successful, there will be no charge for this attempt.